|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Guo X and Cui Z: Current diagnosis and
treatment of pancreatic cancer in China. Pancreas. 31:13–22.
2005.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Long J, Luo GP, Xiao ZW, Liu ZQ, Guo M,
Liu L, Liu C, Xu J, Gao YT, Zheng Y, et al: Cancer statistics:
Current diagnosis and treatment of pancreatic cancer in Shanghai,
China. Cancer Lett. 346:273–277. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bosetti C, Bertuccio P, Negri E, La
Vecchia C, Zeegers MP and Boffetta P: Pancreatic cancer: overview
of descriptive epidemiology. Mol Carcinog. 51:3–13. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang S, Zhang Y, Zhao X, Wang J and Shang
J: microRNA-361 targets Wilms' tumor 1 to inhibit the growth,
migration and invasion of non-small-cell lung cancer cells. Mol Med
Rep. 14:5415–5421. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lin P, Pang Q, Wang P, Lv X, Liu L and Li
A: The targeted regulation of Gli1 by miR-361 to inhibit
epithelia-mesenchymal transition and invasion of esophageal
carcinoma cells. Cancer Biomark. 21:489–498. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Isaji S, Kawarada Y and Uemoto S:
Classification of pancreatic cancer: Comparison of Japanese and
UICC classifications. Pancreas. 28:231–234. 2004.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Peng DY, Song H and Liu LB:
Resveratrol-downregulated phosphorylated liver kinase B1 is
involved in senescence of acute myeloid leukemia stem cells. J
Huazhong Univ Sci Technolog Med Sci. 35:485–489. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4(e05005)2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kang KA, Piao MJ, Madduma Hewage SR, Ryu
YS, Oh MC, Kwon TK, Chae S and Hyun JW: Fisetin induces apoptosis
and endoplasmic reticulum stress in human non-small cell lung
cancer through inhibition of the MAPK signaling pathway. Tumour
Biol. 37:9615–9624. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mondal A, Biswas R, Rhee YH, Kim J and Ahn
JC: Sulforaphene promotes Bax/Bcl2, MAPK-dependent human gastric
cancer AGS cells apoptosis and inhibits migration via EGFR,
p-ERK1/2 down-regulation. Gen Physiol Biophys. 35:25–34.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yeo TP, Hruban RH, Leach SD, Wilentz RE,
Sohn TA, Kern SE, Iacobuzio-Donahue CA, Maitra A, Goggins M, Canto
MI, et al: Pancreatic cancer. Curr Probl Cancer. 26:176–275.
2002.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yonemori K, Kurahara H, Maemura K and
Natsugoe S: MicroRNA in pancreatic cancer. J Hum Genet. 62:33–40.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Furtek SL, Backos DS, Matheson CJ and
Reigan P: Strategies and approaches of targeting STAT3 for cancer
treatment. ACS Chem Biol. 11:308–318. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kıvanç G, Kalliope ND, Ezgi KA, Katrin JC,
Jiaoyu A, Marina L and Hana A: The role of autophagy in pancreatic
cancer: From bench to the dark bedside. Cell.
9(1063)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xu Z, Li C, Qu H, Li H, Gu Q and Xu J:
MicroRNA-195 inhibits the proliferation and invasion of pancreatic
cancer cells by targeting the fatty acid synthase/Wnt signaling
pathway. Tumour Biol. 39(1010428317711324)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang G, Liu D, Long G, Shi L, Qiu H, Hu
G, Hu G and Liu S: Downregulation of microRNA-181d had suppressive
effect on pancreatic cancer development through inverse regulation
of KNAIN2. Tumour Biol. 39(1010428317698364)2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gu DN, Jiang MJ, Mei Z, Dai JJ, Dai CY,
Fang C, Huang Q and Tian L: microRNA-7 impairs autophagy-derived
pools of glucose to suppress pancreatic cancer progression. Cancer
Lett. 400:69–78. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kanitz A, Imig J, Dziunycz PJ, Primorac A,
Galgano A, Hofbauer GF, Gerber AP and Detmar M: The expression
levels of microRNA-361-5p and its target VEGFA are inversely
correlated in human cutaneous squamous cell carcinoma. PLoS One.
7(e49568)2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sun JJ, Chen GY and Xie ZT:
MicroRNA-361-5p inhibits cancer cell growth by targeting CXCR6 in
hepatocellular carcinoma. Cell Physiol Biochem. 38:777–785.
2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ma F, Song H, Guo B, Zhang Y, Zheng Y, Lin
C, Wu Y, Guan G, Sha R and Zhou Q: miR-361-5p inhibits colorectal
and gastric cancer growth and metastasis by targeting
staphylococcal nuclease domain containing-1. Oncotarget.
6(17404)2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Liu D, Tao T, Xu B, Chen S, Liu C, Zhang
L, Lu K, Huang Y, Jiang L, Zhang X, et al: MiR-361-5p acts as a
tumor suppressor in prostate cancer by targeting signal transducer
and activator of transcription-6 (STAT6). Biochem Biophys Res
Commun. 445:151–156. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chen W, Wang J, Liu S, Wang S, Cheng Y,
Zhou W, Duan C and Zhang C: MicroRNA-361-3p suppresses tumor cell
proliferation and metastasis by directly targeting SH2B1 in NSCLC.
J Exp Clin Cancer Res. 35(76)2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liu J, Zhu J, Xiao Z, Wang X and Luo J:
BBOX1-AS1 contributes to colorectal cancer progression by sponging
hsa-miR-361-3p and targeting SH2B1. FEBS Open Bio: Jan 27, 2020
(Epub ahead of print).
|
|
30
|
Hu J, Li L, Chen H, Zhang G, Liu H, Kong
R, Chen H, Wang Y, Li Y, Tian F, et al: MiR-361-3p regulates
ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal
adenocarcinoma. Cell Death Dis. 9(807)2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhao D and Cui Z: MicroRNA-361-3p
regulates retinoblastoma cell proliferation and stemness by
targeting hedgehog signaling. Exp Ther Med. 17:1154–1162.
2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lago TS, Silva JA, Lago EL, Carvalho EM,
Zanette DL and Castellucci LC: The miRNA 361-3p, a regulator of
GZMB and TNF is associated with therapeutic failure and longer time
healing of cutaneous Leishmaniasis Caused by L. (viannia)
braziliensis. Front Immunol. 9(2621)2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ji Y, Wang D, Zhang B and Lu H: MiR-361-3p
inhibits β-amyloid accumulation and attenuates cognitive deficits
through targeting BACE1 in Alzheimer's disease. J Integr Neurosci.
18:285–291. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Li Y, Xi Z, Chen X, Cai S, Liang C, Wang
Z, Li Y, Tan H, Lao Y and Xu H: Natural compound Oblongifolin C
confers gemcitabine resistance in pancreatic cancer by
downregulating Src/MAPK/ERK pathways. Cell Death Dis.
9(538)2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Roy SK, Srivastava RK and Shankar S:
Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of
FOXO transcription factor, leading to cell cycle arrest and
apoptosis in pancreatic cancer. J Mol Signal. 5(10)2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yang K, Li Y, Lian G, Lin H, Shang C, Zeng
L, Chen S, Li J, Huang C, Huang K and Chen Y: KRAS promotes tumor
metastasis and chemoresistance by repressing RKIP via the MAPK-ERK
pathway in pancreatic cancer. Int J Cancer. 142:2323–2334.
2018.PubMed/NCBI View Article : Google Scholar
|
